Nancy Carteron, M.D., FACR (original) (raw)

Dr. Nancy Carteron is an ABMS board certified rheumatologist and internist, and multidisciplinary Sjögren’s clinic team member. She is a health sciences clinical professor at the University of California, Berkeley School of Optometry, and a clinical professor of medicine (volunteer) at the University of California, San Francisco School of Medicine. Current Co-Investigator of the Sjogren’s Disease Team of Accelerating Medicines Partnership – Autoimmune and Immune-Mediated Diseases Program.

Education

• Ohio Wesleyan University, BA
• Johns Hopkins School of Medicine, MD
• Duke University Medical Center, Internship
• Stanford University Medical Center, Residency
• University of California-San Francisco, Fellowship

Certifications

• American Board of Internal Medicine – Internal Medicine and Rheumatology
• Fellow of American College of Rheumatology (FACR)

Professional Accomplishments

• Co-founder of HealthWell Foundation
• Rheumatology chair, Clinical Practice Guidelines Program, medical and scientific editor of Sjögren’s Quarterly and past advisory board chair, Sjögren’s Foundation
• Healthcare Professional Leadership Award, Sjögren’s Foundation 2016

Affiliations

• American College of Rheumatology (ACR)
• HealthWell Foundation (HWF)
• Sjögren’s Clinic
• Stress Pal Medical Advisor
• Sjögren’s Foundation
• San Francisco Marin Medical Society (SFMMS)
• California Medical Association (CMA)

ABOUT OUR MEDICAL REVIEW PROCESS

At Healthline Media, we are committed to providing every individual with clear, credible, evidence-based health and wellness information. To be your most trusted source of information, our content is medically reviewed to verify the clinical accuracy of our content, images, products, and services. Medical review is provided by members of the Healthline Medical Network. The clinicians in the Medical Network bring extensive experience from across the spectrum of medical specialties, as well as their perspective from years of clinical practice, research, and patient advocacy. Read more about our process